ArticleCell discovery2026
Structural basis of the transport mechanism of hBGT1.
Article in Cell discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In the kidney and liver, the betaine/γ-aminobutyric acid (GABA) transporter 1 (BGT1) transports betaine to maintain the osmotic balance of renal medullary cells and reduce the toxicity of homocysteine accumulation. In the brain, BGT1 reuptakes GABA from the synaptic cleft into glial cells to terminate GABAergic signaling. Despite its importance, the molecular mechanisms of BGT1 substrate recognition and ion coupling remain unknown. Here, we resolved the cryo-electron microscopy structures of BGT1 in complex with two substrates, GABA and betaine, as well as the substrate-free form without any fiducial marker. The substrate-bound complex elucidates the mechanism by which BGT1 recognizes chemically distinct GABA and betaine. These structures are trapped in occluded and inward-open states, elucidating the structural basis for conformational transitions. Furthermore, we proposed a Na3-binding site and investigated the functional role of the Na3 site in limiting reverse transport and promoting substrate accumulation. These insights improve our understanding of substrate recognition, conformational transitions, and ion coupling mechanisms in BGT1, as well as other neurotransmitter transporters.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.